Evaluation of Effect of Triterpenes and Limonoids on Cell Growth, Cell Cycle and Apoptosis in Human Tumor Cell Lines

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 10, 2010, Pages 769-776

  Cazal, Cristiane M ^a   Choosang, Kantima ^b,c   Severino, Vanessa Gisele P ^a   Soares, Márcio S ^a   Sarria, André Lúcio F ^a   Fernandes, João B ^a   Silva, Maria Fátima G F ^a   Vieira, Paulo Cezar ^a   Pakkong, Pannee ^c   Almeida, Gabriela M ^b   Vasconcelos, M Helena ^b   Nascimento, Maria S J ^b   Pinto, Madalena M M ^b  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b UNIVERSITY OF PORTO   (Portugal)

^c KASETSART UNIVERSITY   (Thailand)

Author keywords

Anticancer; Apoptosis; Breast adenocarcinoma; Cell cycle arrest; Limonoids; Melanoma; Non small lung cancer; Triterpenes

Indexed keywords

22 HYDROXYTIRUCALLA 7,24 DIENE 2,3-DIONE; 6 ACETOXYGEDUNIN; 6ALPHA ACETOXY 14BETA,15BETA EPOXYAZADIRONE; 7 DEACETOXY 7 OXOGEDUNIN; 7 DEACETOXYGEDUNIN; ANTINEOPLASTIC AGENT; CABRALEADIOL; CEDRELONE; DOXORUBICIN; GEDUNIN; GUYANIN; LIMONOID; OCOTILLONE; ODORADOL; ODORATOL; ODORATONE; TOONACILIN; TRITERPENE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL CYCLE ARREST; CELL STRAIN A375 C5; CELL STRAIN MCF 7; CELL STRAIN NCI H460; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MELANOMA CELL;

EID: 79952740999     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152010794728620     Document Type: Article

References (44)

1. Altmann, K.-H.; Gertsch, J. Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents. Nat. Prod. Rep., 2007, 24, 327-357.
2. Baker, D. D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep., 2007, 24, 1225-1244.
3. Saklani, A.; Kutty, S. K. Plant-derived compounds in clinical trials. Drug Discov. Today, 2007, 13, 161-171.
4. Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvasnica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek, J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep., 2006, 23, 394-411.
5. Pisha, E.; Chai, H.; Lee, I. S.; Changwedera, T. E.; Farnsworth, N. R.; Cordell, G.A., Beecher, C. W.; Fong, H. H., Kinghorn, A. D.; Brown, D.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. (N.Y.), 1995, 1, 1046-1051.
6. Jeremias, I.; Steiner, H. H.; Debatin, A.; Harold-Mende, C.; Benner, A. Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells. Acta Neurochir. (Wein),2004, 146, 721-729.
7. Gopal, D. V. R.; Narkar, A. A.; Badrinath, Y.; Mishra, K. P.; Joshi, D. S. Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl. Toxicol. Lett., 2005, 155, 343-351.
8. Fulda, S.; Scaffidi, C.; Susin, S. A.; Krammer, P.H.; Kroemer, G.; Peter, M. E.; Debatin, K.M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem., 1998, 273, 33942-33948.
9. Wick, W., Grimmel, C.; Wagenknecht, B.; Dichgans, J.; Weller, M. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther., 1999, 289, 1306-1312.
10. Melzig, M.F.; Bormann, H. Betulinic acid inhibits aminopeptidase N activity. Planta Med., 1998, 64, 655-657.
11. pH adapted human melanoma cells to hypothermia. Int. J. Hypothermia, 2002, 18, 153-164.
12. Glaser, T.; Winter, S.; Groscurth, P.; Safayhi, H.; Sailer, E. R.; Ammon, H. P. T.; Schabet, M.; Weller, M. Boswellic acid and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br. J. Cancer, 1999, 80, 756-765.
13. Winking, M.; Sarikaya, S.; Rahmanian, A.; Jodicke, A.; Boker, D. K. Boswellic acids inhibit glioma growth: a new treatment option? J. Neurooncol., 2000, 46, 97-103.
14. Xia, L.; Chen, D.; Han, R.; Fang, Q.; Waxman, S.; Jing, Y. Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells. Mol. Cancer Ther., 2005, 4, 381-388.
15. Kunnumakkara, A. B.; Nair, A. S.; Pandey, B. S. M. K; Aggarwal, B. B. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol. Cancer Res., 2009, 7, 118-128.
16. Hoernlein, R.F.; Orlikkowsky, T.; Zehrer, C.; Niethammer, D.; Sailer, E. R.; Sommer, T.; Dannecker, G. E.; Ammon, H.P.T. Acetyl-11-keto-b-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibit topoisomerase I. J. Pharmacol. Exp. Ther., 1999, 288, 613-619.
17. Streffer, J. R.; Bitzer, M.; Schabet, M.; Dichgans, J.; Keller, M. Response of radiochemotherapy-associated cerebral edema to a hytotherapeutic agent, H15. Neurology, 2001, 56, 1219-1221.
18. Subbaramaiah, K.; Michaluart, P.; Sporn, M. B.; Dannenberg, A.J. Usolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res., 2000, 60, 2399-2404.
19. Lee, H. Y., Chung, H. Y., Kim, K. H.; Lee, J. J.; Kim, K. W. Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol., 1994, 120, 513-518.
20. Niikawa, M.; Hayashi, H.; Sato, T.; Nagase, H.; Kito H. Isolation of substances from glossy privet (Ligustrum lucidum Ait.) inhibiting the mutagenicity of benzo[a]pyrene in bacteria. Mutat. Res., 1993, 319, 1-9.
21. Sohn, K. H.; Lee, H. Y.; Chung, H. Y.; Kim, K. H.; Lee, J. J.; Kim K. W. Anti-angiogenic activity of triterpene acids. Cancer Lett., 1995, 94, 213-218.
22. Reyes-Zurita, F.; Rufino-Palomares, E. E.; Lupiáñez, J. A.; Cascante, M. Maslinic acid, a natural triterpene from Olea europea L.; induces apoptosis in HT29 human cólon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett., 2009, 273, 44-54.
23. Mizushina, Y.; Iida, A.; Ohta, K.; Sugawara, F.; Sakagichi, K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem. J., 2000, 350, 757-763.
24. Qiu, S.X.; van Hung, N.; Xuan, L.T.; Gu, J.Q.; Lobkovsky, E., Khanh, T.C.; Soejarto, D.D.; Clardy, J.; Pezzuto, J.M.; Dong, Y.; Tri, M.V.; Huong, L.M.; Fong, H.H.S. A pregnane steroid from Aglaia lawii and structure confirmation of cabraleadiol monoacetate by X-ray crystallography. Phytochemistry, 2001, 56, 775-780.
25. Kashiwada, Y.; Sekiya, M.; Yamazaki, K.; Ikeshiro, Y.; Fujioka, T.; Yamagushi, T.; Kitagawa, S.; Takaishi, Y. Triterpenoids from the floral spikes of Betula platyphylla var. japonica and their reversing activity against multidrug-resistant cancer cell. J. Nat. Prod., 2007, 70, 623-627.
26. Silva, V. P.; Oliveira, R.R.; Figueiredo, M.R. Isolation of limonoidsfrom seeds of Carapa guianensis Aublet (Meliaceae) by high-speed countercurrent chromatography. Phytochem. Anal., 2008, 26, 77-81.
27. de Paula, J. R.; Castro-Gamboa, I.; Neto, J. O.; Silva, M. F.; Fo, E. R.; Fernandes, J. B.; Vieira, P. C.; Pinheiro, A. L. Chemistry of Cedrela odorata graft and speculations on the induced resistance against Hypipyla grandella. An. Acad. Bras. Ci.; 1998, 70, 737-742.
28. de Paula, J. R.; Vieira, I. J. C.; Silva, M. F.; Fo, E. R.; Fernandes, J. B.; Vieira, P. C.; Pinheiro, A. L.; Vilela, E. F. Sesquiterpenes, triterpenoids, limonoidsand flavonoids of Cedrela odorata graft andspeculations on the induced resistance against Hypipyla grandella. Phytochemistry, 1997, 44, 1449-1454.
29. Neto, J. O.; Agostinho, S. M. M.; Silva, M. F.; Vieira, P. C.; Fernandes, J. B.; Pinheiro, A. L.; Vilela, E. F. Limonoids from seeds of Toona ciliata and their chemosystematic significance. Phytochemistry, 1995, 38, 397-401.
30. Neto, J. O.; Silva, M. F.; Fo, E. R.; Fernandes, J. B.; Vieira, P. C.; Pinheiro, A. L. Limonoids from seeds of Toona ciliata. Phytochemistry, 1998, 49, 1396-1373.
31. Severina, V. G.; Cazal, C. M.; Forim, C. M.; Silva, M. F.; Rodrigues-Filho, E.; Fernandes, J. B.; Vieira, P. C. Isolation ofsecondary metabolites from Hortia oreadica (Rutaceae) leaves throgh highspeed counter current chromatography. J. Chromatogr. A, 2009, 1216, 4275-4281.
32. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenny, S.; Boyd, M. R. New calorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 1990, 82, 1107-1112.
33. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, A.; Paul, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J. Boyd, M. Feasibility of a highflux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 1991, 83, 757-766.
34. Palmeira, A.; Paiva, A.; Sousa, E.; Seca, H.; Almeida, G. A.; Lima, R. T.; Fernandes, M. T.; Pinto, M.; Vasconcelos, M. H. Insightsinto the in vitro antitumor mechanism of action of a new Pyranoxanthone. Chem. Biol. Drug Des., 2010, 76, 43-58.
35. Phongmaykin, J.; Kumamoto, T.; Ishikawa, T.; Suttisri, R.; Saifah, E. A new sesquiterpene and other terpenoid constituents of Chisocheton penduliflorus. Arch. Pharm. Res., 2008, 31, 21-27.
36. Koul, O.; Isman, M. B. Toxicity of the limonoids allelochemical cedrelone to noctuid larvae. Entomol. Exp. Appl., 1992, 64, 281-287.
37. Gopalakrishnan, G.; Singh, N. D. P.; Kasinath, V.; Malathi, R. Rajan, S. S.; Photooxidation of cedrelone, a tetranortriterpenoid from Toona ciliata. Photochem. Photobiol., 2000, 72, 464-466.
38. Govindachari, T. R.; Suresh, G.; Gopalakrishnan, G.; Masilamani, S.; Banumathi, B.; Antifungal activity of some tetranortriterpenoids. Fitoterapia, 2000, 71, 317-320.
39. Maneerat, W.; Laphookhieo, Koysomboon, S.; Chantrapromma, K. Antimalarial, antimycobacterial and cytotoxic limonoids from Chisocheton siamensis. Phytomedicine, 2008, 15, 1130-1134.
40. Brandt, G. E. L.; Schmidt, M. D.; Prisinzano, T. E.; Blagg, B. S. J. Gedunin, a novel Hsp90 inhibitor: semisynthesis of derivativesand preliminary structure-activity relationships. J. Med. Chem., 2008, 51, 6495-6502.
41. Lamb, J.; Crawford, E. D.; Peck, D.; Modell, J. W.; Blat, I. C.; Wrobel, M. J.; Lerner, J.; Brunet, J. P.; Subramanian, A.; Ross, K. N.; Reich, M.; Hieronymus, H., Wei, G.; Amstrong, S. A.; Haggarty, S. J.; Clemons, P. A.; Wei, R.; Carr, S. A. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 2006, 313, 1929-1935.
42. Hieronymus, H., Lamb, J.; Ross, K. N.; Peng, X. P.; Clement, C.; Rodina, A.; Nieto, M.; Du, J.; Stegmaier, K.; Raj, S. M.; Maloney, K. N.; Clardy, J.; Hahn, W. C.; Chiosis, G.; Golub, T. R.; Gene expression signature-based chemical genomic prediction identifies a novel class of Hsp90 pathway modulators. Cancer Cell, 2006, 10, 321-330.
43. Prasad, S.; Madan, E.; Nigam, N.; Roy, P.; George, J.; Shukla, Y.; Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NFkappaB signaling pathways. Cancer Biol. Ther., 2009, 8, 1632-1639.
44. Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvanica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek J. Pharmacological activities of natural triterpenoids and their therapeutic implication. Nat. Prod. Rep., 2006, 23, 394-411.